Skip to main content

MoneyWorks4Me

Lupin submits press release

05 Aug 2019 Evaluate

Lupin has informed about submission of a Press Release as regards receipt of the Establishment Inspection Report from the US FDA for the Company's Aurangabad facility. The inspection was conducted between May 6, 2019 and May 15, 2019. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..